author={W. Boehncke and M. Sch{\"o}n},
  journal={The Lancet},
Psoriasis is an immune-mediated, genetic disease manifesting in the skin or joints or both. A diverse team of clinicians with a range of expertise is often needed to treat the disease. Psoriasis provides many challenges including high prevalence, chronicity, disfiguration, disability, and associated comorbidity. Understanding the role of immune function in psoriasis and the interplay between the innate and adaptive immune system has helped to manage this complex disease, which affects patients… Expand
19 Citations

Paper Mentions

Interventional Clinical Trial
Tyrosine Kinase inhibitors (TKIs) have become standard of care in patients with EGFR mutations in non-small cell lung cancer and other EGFR-mutated cancers. However, TKIs are… Expand
ConditionsAcneiform Eruptions, Cancer, Treatment-Related
Interventional Clinical Trial
To evaluate the effect and safety of treatment of psoriasis by human umbilical cord-derived mesenchymal stem cel  
Interventional Clinical Trial
Assessment of quality of life after Spa therapy (4 ½ months follow-up) in the treatment of plaque psoriasis: Spa versus usual care in patients with plaque psoriasis.  
ConditionsPlaque Psoriasis
Saliva as a Future Field in Psoriasis Research
Psoriatic arthritis in Japan: difference in clinical features and approach to precision medicine.
  • Y. Tanaka
  • Medicine
  • Clinical and experimental rheumatology
  • 2016
Serum peptides as putative modulators of inflammation in psoriasis.
Shaping the spectrum - From autoinflammation to autoimmunity.
Systematic screening and identification of novel psoriasis-specific genes from the transcriptome of psoriasis-like keratinocytes
Macrophage activation in human diseases.
Drug nanocarriers to treat autoimmunity and chronic inflammatory diseases.